"Promoting academic research on rare diseases in Hauts-de-France and Champagne-Ardenne"
SATT Nord and the Rare Diseases Foundation are pooling their complementary expertise to promote the emergence and maturation of research projects in the field of rare diseases in the Hauts-de-France and Champagne-Ardenne regions.
In response to the joint call for projects launched on February 14, 2018, 10 applications were submitted by researchers and hospital practitioners from the centers of excellence in research and care in Lille, Amiens, and Reims. The aim was to identify emerging projects with high potential for innovation and technology transfer in the areas of diagnostic and prognostic approaches, medical devices, preventive and therapeutic approaches, as well as humanities and social sciences aspects for all rare diseases (including rare cancers).
Following a joint evaluation process by SATT Nord and the Rare Diseases Foundation, four projects were selected.
These four projects are now entering a pre-maturation phase at SATT Nord, where experts linked to the Rare Diseases Foundation will assess their potential for commercialization. The aim is to support these future innovations in the development of therapeutic solutions that will benefit patients and their families.
| PROJECTS | THEME | CARRIER – LABORATORIES |
| DOSINDYGO | Intraoperative photodynamic therapy for glioblastoma | Maximilien VERMANDEL Laboratoire OncoThaï (UMR1189) Institut de Biologie de Lille |
| ARTMODENF | Prosthetic rehabilitation in pediatric dentistry |
Marie-Paule GELLE EA 4691 « BIOS » – URCA Université de Reims – CHU de Reims |
| SLERO-PROT | Characterization of diagnostic and prognostic blood biomarkers in systemic scleroderma | David LAUNAY U 995 INSERM -Université de Lille CHRU de Lille |
| IMUCOSAC | Modulation of bone inflammation and neuroinflammation in mucopolysaccharidoses, rare pediatric genetic diseases | Jérôme AUSSEIL et José KOVENSKY EA MP3CV /LG2A-UMR7378 CNRS Université de Picardie Jules Verne |
Director of the Foundation, Professor Daniel Scherman
The Rare Diseases Foundation is a non-profit scientific and technical cooperation foundation whose mission is to accelerate research into all rare diseases. Its activities take the form of several national calls for projects each year and on-the-ground support for researchers and university hospital staff, including putting them in touch with developers in the pharmaceutical and biotechnology industries.
We are very pleased with the launch of this call for expressions of interest and the work carried out in collaboration with SATT Nord. It is fully in line with our mission: to support the development of the most mature projects and accelerate access to new innovative treatments.
The benefits of a long-term partnership are fundamental to improving the therapeutic and psychosocial care of patients."
“The collaboration between SATT Nord and the Rare Diseases Foundation is the result of a shared desire to develop concrete projects in cutting-edge medical research. The four projects selected offer real hope for thousands of patients, and we are keen to play an active role in this.
This pre-selection phase has enabled us to identify their strong application potential. From now on, the researchers and project leaders will be jointly supported by our teams to ensure they achieve sufficiently conclusive results. This process will obviously take time. But SATT Nord and the Rare Diseases Foundation will provide the necessary resources to ensure that innovative technologies are put to use in new treatments."